Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Use of Oral Droxidopa to Improve Arterial Pressure and Reduce Vasoactive Drug Requirements During Persistent Vasoplegic Syndrome After Cardiac Transplantation. J Cardiothorac Vasc Anesth 2016 Dec;30(6):1624-1626

Date

05/11/2016

Pubmed ID

27161180

DOI

10.1053/j.jvca.2015.12.013

Scopus ID

2-s2.0-84965042758 (requires institutional sign-in at Scopus site)   5 Citations

Author List

Zundel MT, Boettcher BT, Feih JT, Gaglianello N, Pagel PS

Authors

Brent Boettcher DO Associate Professor in the Anesthesiology department at Medical College of Wisconsin
Nunzio A. Gaglianello MD Associate Professor in the Medicine department at Medical College of Wisconsin
Michael Tracy Zundel MD Associate Professor in the Anesthesiology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Administration, Oral
Antiparkinson Agents
Arterial Pressure
Droxidopa
Fatal Outcome
Female
Heart Transplantation
Humans
Middle Aged
Multiple Organ Failure
Postoperative Complications
Syndrome
Vasoplegia